e-learning
resources
Virtual 2020
Pre-Congress Content
Pharmacological management of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pharmacological management and risk of mortality after first COPD hospitalization (HERA)
C. Janson (Uppsala, Sweden), B. Nwaru (Gothenburg, Sweden), F. Wiklund (Uppsala, Sweden), G. Telg (Södertälje, Sweden), M. Ekström (Lund, Sweden)
Source:
Virtual Congress 2020 – Pharmacological management of COPD
Session:
Pharmacological management of COPD
Session type:
E-poster session
Number:
2427
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Janson (Uppsala, Sweden), B. Nwaru (Gothenburg, Sweden), F. Wiklund (Uppsala, Sweden), G. Telg (Södertälje, Sweden), M. Ekström (Lund, Sweden). Pharmacological management and risk of mortality after first COPD hospitalization (HERA). 2427
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Initial treatment and mortality in COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 578s
Year: 2003
Pharmacological treatment, mortality and hospitalisations
Source: Annual Congress 2004 - Pharmacoepidemiology of obstructive lung disease: beyond clinical trials
Year: 2004
Long term non-invasive ventilation (LT-NIV) reduces mortality and the risk of hospital readmission in systemic COPD patients
Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes
Year: 2013
In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Predictors of long-term mortality after hospitalization for COPD; A Scandinavian multicentre study
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014
Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021
Management of patients with asthma or COPD and cardiovascular disease: risks
versus
benefits
Source: Eur Respir Monogr 2020; 88: 66-81
Year: 2020
Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia
Source: Eur Respir J 2014; 43: 36-42
Year: 2004
The impact on risk-factor analysis of different mortality outcomes in COPD patients
Source: Eur Respir J 2008; 32: 629-636
Year: 2008
Pilot: identification of rehospitalization risk factors for patients with COPD
Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital
Year: 2005
Predictors of mortality in COPD patients after hospitalization due to an exacerbation
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019
No impact of statins on time to first COPD exacerbation or all-cause mortality
Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data
Year: 2021
Predictors of mortality in COPD
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
Predictors of mortality in COPD
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008
Risk factors for all-cause hospital readmission following exacerbation of COPD: a systematic review and meta-analysis
Source: Eur Respir Rev, 29 (156) 190166; 10.1183/16000617.0166-2019
Year: 2020
Management of acute pulmonary thrombo-embolic disease (PTE) linking mortality risk to treatment strategies
Source: Annual Congress 2009 - Pulmonary circulation II
Year: 2009
Risk factors for mortality in patients with COPD exacerbation
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009
Effect of screening for undiagnosed COPD on respiratory hospitalisation and mortality; 4 year follow up of the TargetCOPD trial
Source: International Congress 2019 – Management of airway diseases in primary care
Year: 2019
Accelerated FEV
1
decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients
Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020
Year: 2021
Preventative care and home treatment in patients at risk of hospitalisation due to exacerbation of COPD.
Source: International Congress 2018 – The many facets of respiratory nursing
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept